Most brand owners switch supplement manufacturers for one of five reasons: the quality drifted, the lead time crept from 45 days to 90, the price rose at renewal, the MOQ no longer fits, or communication broke down.
All five are legitimate. None of them are urgent enough to justify what usually happens next, which is a switch that takes four months, produces a batch that does not quite match the old one, and burns a packaging print run in the process.
A manufacturer switch is not a purchase. It is a transfer of a validated process, and it has four workstreams that must run in parallel: formula and specification transfer, regulatory and label work, supply continuity, and a validation batch. Miss any one and the launch date moves.
The short answer
A realistic switch takes 12 to 16 weeks from first contact to saleable stock, and the critical path is almost never the production line. It is the combination of a validation batch, stability data, and the label and packaging reprint.
| Workstream | Duration | What actually takes the time |
|---|---|---|
| Handover pack and quotes | 1 to 2 weeks | Getting the real formula, not the marketing sheet |
| Formula matching and sample | 2 to 4 weeks | Sending materials, trial batch, sensory and assay check |
| Validation batch | 3 to 5 weeks | Scheduling, production, QC release |
| Stability (accelerated) | 4 to 8 weeks | Runs in parallel, but gates your shelf-life claim |
| Label, artwork, packaging | 2 to 5 weeks | Dielines, barcodes, regulatory review, print run |
| Regulatory notification | 2 to 6 weeks | Market dependent, runs in parallel |
| Freight and first delivery | 3 to 5 weeks | Ocean or air, plus customs |
Add them wrong and you get 6 months. Run them in parallel, with the validation batch booked before the artwork is finalised, and 12 to 16 weeks is achievable.
What to prepare before you talk to anyone
The single biggest cause of a slow switch is a brand owner who does not actually own their formula on paper. If your current manufacturer holds the specification, you are negotiating from a weak position and you will pay for it in time.
Build a handover pack with these seven documents:
- Quantitative formula, with every ingredient, its exact amount per batch (not percentages only), the overage applied, and the excipient grades.
- Finished product specification: fill weight, capsule or tablet size, hardness, disintegration, moisture, appearance.
- Three recent batch records, or at least the manufacturing instructions and the in-process controls.
- COA history for the last three batches, including the third-party assay results.
- Stability data already generated, with the study conditions and the shelf-life conclusion.
- Artwork source files: label in vector format, dielines, barcode numbers, and the exact claim wording in use.
- Packaging supplier details for bottles, caps, labels and cartons, plus the current stock level and the run-out date.
If you cannot get items 1 and 4 from your existing supplier, assume the switch will take longer and budget for a full reformulation plus a new stability study.
The formula question: match it, or redevelop it?
There are only two honest options, and the quote should tell you which one you are buying.
Match the existing formula. The new manufacturer reproduces your formula exactly, using the same ingredient grades and the same overage. This is faster and preserves your label and your stability data, but it requires a real quantitative formula. A "proprietary blend" label with total milligrams and no ratios cannot be matched. Nobody can reverse-engineer a ratio from a label, and a supplier who says they can is guessing.
Redevelop the formula. This is often cheaper per unit because the new manufacturer uses their own platform formula and their own ingredient suppliers. It also means a new label, new stability data, and a product that is not identical to what your customers already bought. For a young brand with no repeat-purchase history this is fine. For a brand with 20,000 existing customers it is a risk.
Ask for the quote to state which path it is priced on. The difference in timeline is usually 4 to 6 weeks.
Why the validation batch is not optional
The first batch at a new plant is a new process, even when the formula is identical. Different equipment, different blending order, different compression tooling, different humidity in the room. The output can differ in colour, hardness, disintegration time and even assay by a few percent.
That is why the switch should include a validation batch that gets:
- Full in-house QC against your finished product specification
- A third-party assay and microbial test, not just the supplier's own lab
- A side-by-side comparison with a retained sample of your current product
- Accelerated stability at 3 months, if you want to keep your existing shelf-life claim
If the validation batch is released against the manufacturer's own spec rather than yours, you have not validated anything.
The regulatory piece people forget
Changing who makes your product changes who is responsible for it. In most markets the brand owner, not the factory, is the one holding the label.
- United States: there is no pre-market approval for dietary supplements, but the label must comply with 21 CFR 101.36 for the Supplement Facts panel, and the manufacturing facility must be registered and subject to FSMA preventive controls. A new facility means new registration details on your records, and possibly a new allergen or organic certification chain.
- European Union: most member states require a food supplement notification before the product is placed on the market, and claims fall under Regulation (EC) No 1924/2006. A new manufacturer in a new country can mean a new notification, even with an unchanged formula.
- Both: if you make organic, halal, NSF or Informed Sport claims, the certification is tied to the facility, not the formula. Switching factories usually means re-certifying.
Budget 2 to 6 weeks for this, and start it in week one, not after the samples are approved.
The supply continuity maths
This is where launches actually die. The old supplier needs a final order; the new supplier needs a first order; your stock has to cover the gap between them.
Work backwards from your run-out date:
| Item | Example |
|---|---|
| Current stock on hand | 4,200 units |
| Monthly sell-through | 1,800 units |
| Run-out date | about 10 weeks |
| Last order to old supplier (lead time 10 weeks) | must be placed now |
| New supplier first delivery | week 12 to 14 |
| Safety buffer needed | 4 to 6 weeks of stock |
If the numbers do not fit, the answer is usually a bridge order from the old supplier at their reorder MOQ, not a faster switch. Trying to compress a switch to beat a stock-out is how brands end up air-freighting a first batch at three times the freight cost.
One more point: do not tell the old supplier you are leaving until the new validation batch is released. Suppliers deprioritise accounts that are leaving, and a final order that slips by three weeks can wipe out the entire plan.
What the switch actually costs
The unit price at the new factory is the smallest number in this table.
| Cost item | Typical range (USD) |
|---|---|
| Samples and trial batch | 300 to 1,500 |
| Validation batch premium (small run) | 500 to 2,000 |
| Accelerated stability study | 800 to 2,500 |
| Label and carton reprint (new dielines) | 600 to 3,000 |
| New plate or die charges | 200 to 800 |
| Regulatory notification or consultant | 300 to 1,500 |
| Obsolete packaging from the old design | varies, often the largest line |
| Air freight to protect a launch date | 2,000 to 8,000 |
A switch is rarely justified by a 5 percent unit price difference. It is justified by a 20 percent difference, a lead time that is 4 weeks shorter, or a quality problem that is costing you reviews.
Five ways switches fail
- The formula is "matched" but the excipients are not. A different grade of magnesium stearate or a different supplier of the same ingredient can change flow and disintegration. Specify grades, not just names.
- Artwork is rebuilt from a PDF. Barcodes get regenerated, claim wording drifts, and the serving size no longer matches the new fill weight. Always supply vector source files and proof against the old printed label.
- The new MOQ is the old reorder MOQ. First-order MOQ at a new factory is usually higher than the reorder minimum you were used to. Check it before you commit to a launch volume.
- No retained samples. Keep at least 20 units of the last batch from the old factory. Without them you cannot prove equivalence, and you cannot answer a customer complaint six months later.
- The regulatory work starts late. It is the cheapest workstream and the one most likely to sit at the end of the queue.
Before you sign with the new manufacturer
- Formula and specification signed off in writing, including overages and excipient grades.
- Validation batch defined, with your spec as the acceptance criteria.
- COA per batch, from a third-party lab, named in the agreement.
- Stability commitment in writing, with conditions and duration.
- First-order MOQ and reorder MOQ stated separately.
- Lead time stated from PO to ex-works, and from ex-works to your door.
- Change control: what happens if they substitute an ingredient or a component.
- Confidentiality and formula ownership, so the next switch is easier than this one.
- Packaging responsibility split: who buys bottles, who buys labels, who owns the dielines.
- Exit terms: what you get if you leave, including your batch records.
Frequently asked questions
Can I keep my existing label when I switch manufacturers?
Only if the formula, fill weight and facility claims stay identical. Any change to the Supplement Facts panel, the ingredients list or a certification claim requires new artwork. Most switches involve at least a small artwork revision.
How long does it take to switch supplement manufacturers?
Twelve to sixteen weeks is realistic if the formula can be matched and packaging is already designed. Add four to eight weeks if the formula has to be redeveloped or a new stability study is needed.
Do I need a new stability study?
If the formula, dosage form and packaging are identical, a bridging or accelerated study is usually enough to support the existing shelf life. If any of those change, plan on a full study.
Will the new manufacturer be cheaper?
Not necessarily. A new factory quotes a first-order MOQ, new tooling and a validation batch. Many brands find the first order costs more than the old price, and the saving appears from the second or third order.
What if my current manufacturer will not release the formula?
Then you do not own your product. The practical route is to have the new manufacturer redevelop the formula from the label and your specification, and accept a new stability study and a new label. It is worth checking your original contract first - ownership clauses are often there and often ignored.
The takeaway
A manufacturer switch is a project, not a purchase order. The formula is the easy part; the schedule is set by the validation batch, the artwork and the stock you have on hand. Prepare the handover pack before you ask for quotes, book the validation batch before the artwork is final, and keep the old supplier running until the new batch is released.
If you are planning a transfer and want a second source quoted against your existing specification, send us the formula and the finished product spec and we will come back with a matching plan, a timeline and a first-order MOQ. We run private label supplement manufacturing and custom formulation from the same plant, so a formula match and a redevelopment quote can be compared side by side.
